Two strong stocks under $30, Pfizer and Nu Holdings, offer resilience and growth in a tough market.

Stocks priced under $30 often get overlooked, but Pfizer and Nu Holdings stand out with solid balance sheets and growth potential. Pfizer, a global biopharma giant, trades around $25 with a strong dividend yield and promising pipeline despite some revenue risks. Nu Holdings, parent of Nubank, offers rapid growth in Latin America with improving profitability and a new U.S. banking charter, despite some credit and currency risks. Both present attractive opportunities for investors seeking stability and growth in a challenging economic environment.